DREYER SCOTT (EVP & Chief Commercial Officer) sold 41.0% of their position (49.98K shares) of COLLEGIUM PHARMACEUTICAL, INC on the open market
Open‑market sale worth $2.02M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/5/2026ACC: 0001746251-26-000004
Officer· EVP & Chief Commercial Officer
Since Jul 2018
-49.98K
Net shares
Net seller
$2.02M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
49.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−46.42K
Price / share
$40.36
Trade value
$1.87M
% of position
38.1%
3/3/2026
121.75K→75.33K
Common Stock
Direct
Shares
−3.56K
Price / share
$40.99
Trade value
$145.88K
% of position
4.7%
3/3/2026
75.33K→71.77K
Total
Net shares
−49.98K
Net value
-$2.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2026 | S · Sale | −46.42K | $40.36 | $1.87M | 38.1% | 121.75K | 75.33K |
| Common Stock Direct | 3/3/2026 | S · Sale | −3.56K | $40.99 | $145.88K | 4.7% | 75.33K | 71.77K |
| Total | −49.98K | -$2.02M | ||||||
Derivative Transactions0
No derivative transactions reported